808
Participants
Start Date
January 26, 2018
Primary Completion Date
July 29, 2021
Study Completion Date
May 3, 2022
Plasma-Lyte 148 (approx. pH 7.4) IV Infusion
Plasma-Lyte 148 (approx. pH 7.4) IV Infusion is a sterile, clear, non-pyrogenic isotonic solution and when administered intravenously is a source of water, electrolytes and calories. Plasma-Lyte 148 intravenous infusion is indicated as a source of water \& electrolytes or as an alkalinising agent.
0.9% SODIUM CHLORIDE 9g/L injection BP
Sodium chloride (0.9% saline) infusion is a sterile, non-pyrogenic solution of sodium chloride in Water for Injections. The concentration of sodium chloride is 154mmol/L. Sodium chloride (0.9%) intravenous infusion is indicated for extra-cellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.
Auckland City Hospital, Auckland
Starship Children's Hospital, Auckland
Sydney Children's Hospital, Randwick
Prince of Wales Hospital, Sydney
Royal Prince Alfred Hospital, Sydney
The Children's Hospital at Westmead, Sydney
Westmead Hospital, Sydney
St Vincent's Hospital (Melbourne) Ltd, Melbourne
Austin Health, Melbourne
Monash Children's Hospital, Melbourne
Monash Medical Centre, Melbourne
Queensland Children's Hospital, Brisbane
Princess Alexandra Hospital, Brisbane
Royal Adelaide Hospital, Adelaide
Sir Charles Gairdner Hospital, Perth
Wellington Hospital, Wellington
Fiona Stanley Hospital, Murdoch
Christchurch Hospital, Christchurch
Australian Government Department of Health and Ageing
OTHER_GOV
Health Research Council, New Zealand
OTHER
Baxter Healthcare Corporation
INDUSTRY
The University of Queensland
OTHER